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Developmentally Regulated Glycosylation
of the CD8 Coreceptor Stalk
Modulates Ligand Binding
stalk being 10–13 residues shorter than that of the 45-
residue CD8 stalk (Kern et al., 1998). The presence of
numerous proline residues plus O-glycans in both stalks
indicate that they assume an extended conformation
(Classon et al., 1992). CD8 glycan adducts change dur-
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CD8 and CD4 expression occur at different develop-The Glycobiology Research and Training Center
mental stages (Reinherz et al., 1980). CD4CD8 double-Department of Cellular and Molecular Medicine
negative (DN) thymocytes first mature into CD4CD8University of California, San Diego
double-positive (DP) thymocytes. If, through a peptide-La Jolla, California 92093
dependent TCR recognition process, these -TCR-
expressing thymocytes are then positively selected to
survive rather than targeted for apoptotic death, theySummary
develop into either CD8 single positive (SP) or CD4 SP
thymocytes ready for peripheral exportation (reviewedThe functional consequences of glycan structural
in Robey and Fowlkes, 1994). Immature and mature thy-changes associated with cellular differentiation are
mocytes also vary considerably in cell-surface glycosyl-ill defined. Herein, we investigate the role of glycan
ation. For example, the plant lectin peanut agglutininadducts to the O-glycosylated polypeptide stalk teth-
(PNA) specifically binds to core 1 O-glycans bearingering the CD8 coreceptor to the thymocyte surface.
terminal galactose residues, staining immature DP corti-We show that immature CD4CD8 double-positive
cal thymocytes brightly (PNA) but mature SP medullarythymocytes bind MHCI tetramers more avidly than ma-
cells only dimly, if at all (PNA) (Reisner et al., 1976;ture CD8 single-positive thymocytes, and that this dif-
Umiel et al., 1982). The functional significance of thisferential binding is governed by developmentally pro-
changing glycosylation pattern during development hasgrammed O-glycan modification controlled by the
not been elucidated, but PNA lectin affinity chromatog-ST3Gal-I sialyltransferase. ST3Gal-I induction and at-
raphy identifies CD8 as one of the few thymocyte surfacetendant core 1 sialic acid addition to CD8 on mature
glycoproteins which can be purified by such differentialthymocytes decreases CD8-MHCI avidity by alter-
lectin reactivity (Wu et al., 1996).ing CD8 domain-domain association and/or orien-
There is increasing evidence that glycan structurestation. Hence, glycans on the CD8 stalk appear to
play regulatory roles in glycoprotein function and im-modulate the ability of the distal binding surface of the
mune responses (Marth, 1999; Lowe, 2001). Since mem-dimeric CD8 globular head domains to clamp MHCI.
brane proximal glycans can affect the orientation of pro-
teins to which they are attached (Rudd et al., 2001), weIntroduction
reasoned that carbohydrate modifications may modu-
late CD8-MHCI glycoprotein interaction. In this study,
The CD8 cell surface glycoprotein is critical for the devel-
therefore, we have examined MHCI binding to DP and
opment and activation of T cells that recognize peptides CD8 SP thymocytes in TCR transgenic (tg) and C57BL/
bound to major histocompatibility complex class I mole- 6 mice and investigated how patterns of CD8 glycosyla-
cules (MHCI) (Reinherz and Schlossman, 1980; Crooks tion affect binding. Glycans apparently stabilize and/or
and Littman, 1994). CD8 is encoded by two distinct orient the CD8 head region in an optimal way to foster
genes, termed CD8 (or Lyt-2) and CD8 (or Lyt-3), the interaction between CD8 and MHCI, independently
whose polypeptide products exist either as disulfide- of the peptide complexed to the latter. This developmental
linked CD8 homodimers or CD8 heterodimers (Di- process is attributable to induction of ST3Gal-I sialyltrans-
Santo et al., 1988; Norment and Littman, 1988). CD8 ferase activity when T cells mature to medullary SP thymo-
and  dimers are each able to bind to MHCI products cytes and results in the sialylation of core 1 O-glycans.
(Kern et al., 1999). Biochemical studies and sequence The presence of sialic acid on core 1 O-glycans down-
analysis show that CD8 and CD8 are transmembrane modulates the strength of CD8-MHCI binding. The impli-
proteins with a similar architecture despite sharing less cations of these findings for thymic selection processes
than 20% sequence identity (Leahy et al., 1992; Gao et are discussed.
al., 1997; Kern et al., 1998). Both have one N-terminal
external Ig-like domain tethered to the transmembrane Results
and cytoplasmic segments by a connecting peptide of-
ten referred to as a stalk. The lengths of the stalk regions C57BL/6 DP Thymocytes Bind MHCI Tetramers
of the CD8 and  chains are different, with the CD8 Irrespective of Peptide Specificity
To directly examine the binding of thymocytes and
splenocytes to the MHCI molecules, we used peptide/3 Correspondence: ellis_reinherz@dfci.harvard.edu
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Figure 1. Reactivity of non-tg C57BL/6 DP
Thymocytes with Both VSV8Kb and dEV8Kb
Tetramers
Three-color FACS analysis of 105 fresh thy-
mocytes and splenocytes from a 4-week-old
C57BL/6 mouse. (a) and (b) show CD4 and
CD8 staining pattern from thymus (DN 
0.6%; DP  89.8%; CD4 SP  8%; and CD8
SP 1.6%) and spleen (CD4 SP 65.4% and
CD8 SP  24.5%), respectively. The normal
thymic developmental sequence is schemati-
cally depicted in (a). (c) shows significant
binding by tetramers to the DP cells (shaded)
(MCF: PE control  2.1; dEV8Kb 132.2;
VSV8Kb  86.1). Note that virtually no tetra-
mer staining is seen among the mature CD4
SP (mean channel fluorescence  3.1–3.3)
and CD8 SP (MCF  3.2–3.5) thymocytes,
although H57 anti-TCR mAb staining is high-
est in those compartments (MCF  1480.8
and 2631.83, respectively) relative to the DP
thymocytes (MCF  111.8). Y axis cell count
scales are: DP  250, CD8 SP  100,
CD4SP 100, and DN100. Likewise, splenic
T cells express high levels of TCR (MCF: CD8
SP  1169.8 and CD4 SP  2381.2), but show
no reactivity with either tetramer (d) (MCF at
2.3–3.7). Results are representative of four in-
dependent experiments. Y axis cell count
scales are both 250.
MHC (pMHCI) tetramers consisting of the murine Kb mol- 70% of DP thymocytes are reactive with the dEV8Kb
tetramer while 62.3% are reactive with the VSV8Kb tetra-ecule complexed with any of three unrelated octapep-
tides, VSV8 (RGYVYQGL), dEV8 (EQYKFYSV), and SIYR mer (Figure 1c). An equivalent reactivity was observed
with the SIYRKb tetramer (data not shown). In contrast,(SIYRYYGL). The VSV8Kb tetramer is the specific cog-
nate ligand for the N15 TCR (Chang et al., 1997), while the CD8 SP, CD4 SP, and DN thymocytes are essentially
unreactive with either pMHC tetramer. Note that thedEV8Kb and SIYRKb tetramers are the specific ligands for
the 2C TCR (Tallquist et al., 1996; Udaka et al., 1996; strong DP thymocyte pMHC reactivity in the absence
of CD8 SP thymocyte staining is all the more strikingGarcia et al., 1998). Using 58cells transfected with
N15 TCR alone, 2C TCR alone, CD8 alone, N15 TCR in view of the fact that the level of TCR expression is
approximately 20-fold less on DP thymocytes relative toplus CD8, or 2C TCR plus CD8 cDNAs as well as
TCR transgenic (tg) mice, we then established condi- SP thymocyte subpopulations (Figure 1c, H57 staining).
Moreover, consistent with a lack of staining in the CD8tions permitting specific staining of the relevant TCRs
with these tetramers (data not shown). To determine SP thymocyte subpopulation is the absence of signifi-
cant dEV8Kb or VSV8Kb staining within the CD8 SPthe pattern of reactivity of the VSV8Kb and the dEV8Kb
tetramer probes in non-tg mice expressing a diversity splenic T cell subset (Figures 1b and 1d). Furthermore,
comparable tetramer (VSV8Kb and dEV8Kb) reactivity ofof TCRs, we stained thymocytes and splenic T cell popu-
lations from C57BL/6 mice under identical conditions. a significant percentage of DP thymocytes observed in
C57BL/6 (H-2b) mice is also present in two other haplo-As shown in Figure 1a, all four thymocyte subsets are
represented in this 4-week-old mouse. Most remarkably, types (H-2k and H-2d) tested (data not shown). Collectively,
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pMHCI tetramer binding to DP thymocytes. To indepen-
dently confirm this set of results, genetically engineered
CD8 knockout mice lacking CD8 (Fung-Leung et al.,
1991) and/or CD8 (Crooks and Littman, 1994) were
examined as well. As shown in Figure 2C, thymocytes
from CD8/ mice do not bind VSV8Kb tetramers. Since
these mice lack both CD8 and  surface components
due to the obligate requirement of CD8 association for
CD8 surface expression, the relative importance of
each subunit is uncertain in the CD8/animals. How-
ever, lack of tetramer staining was also observed in
thymocytes from CD8/ mice even though CD8 ho-
modimers are surface expressed as judged by FACS
analysis (Figure 2D). Prior studies have implied that
CD8 is the only isoform of CD8 found on thymocytes
(Walker et al., 1984). Although not shown, sequential
immunoprecipitation studies confirm that CD8 heter-
odimers account for 99% of all surface CD8 dimers in
the thymus. In conjunction with the current binding data,
it is clear that CD8 heterodimers are responsible for
MHCI binding.
Using RAG-2/ mice deficient in TCRs as a result of
deletion of the TCR gene rearrangement mechanism (Shin-
kai et al., 1992), the contribution of the TCR to DP-VSV8Kb
tetramer interaction was examined. As seen in Figure
2, the CD8 heterodimer, but not the TCR, is required
for binding to VSV8Kb. For example, in RAG-2/ mice,Figure 2. CD8 Requirement for Kb Binding to C57BL/6 DP Thymocytes
introduction of a tg TCR  chain induces maturation of
(A) VSV8Kb tetramer staining of C57BL/6 thymocytes. In this and all
thymocytes from the DN to DP stage (Shinkai and Alt,subsequent dot plots, the Y axis represents tetramer staining and
1994). Although the TCR  heterodimer is not ex-the X axis represents anti-CD8 reactivity.
(B) Preincubation of thymocytes with saturating concentrations of pressed on these thymocytes due to a lack of TCR
the anti-CD8 mAb, 53–5.8, blocks tetramer binding. chains, VSV8Kb staining of RAG-2/ thymocytes is
(C) Absence of tetramer staining on CD8/ thymocytes that lack clearly evident (Figure 2E). In contrast, RAG-2/ thy-
cell surface CD8  and  receptors. mocytes are blocked at the DN thymocyte stage; com-
(D) CD8/ thymocytes fail to bind VSV8Kb tetramers.
parable FACS analysis shows both absence of CD8 ex-(E) VSV8Kb tetramer reactivity with DP thymocytes from TCR RAG-
pression and failure of thymocytes to stain with the2/ mice.
(F) Lack of VSV8Kb staining of RAG-2/ thymocytes. VSV8Kb tetramer (Figure 2F). However, 14 days after
(G) VSV8Kb tetramers stain DP RAG-2/ thymocytes 14 days after intraperitoneal administration of the anti-CD3 mAb,
i.p. injection with an anti-CD3e mAb (145-2C11). 2C11, RAG-2/ thymocytes have transited from the DN
to the DP developmental stage (Shinkai and Alt, 1994).
Tetramer binding is concomitantly observed with this
the above results demonstrate that there is peptide-indif- developmental transition (Figure 2G). The RAG-2/
ferent MHCI reactivity intrinsic to the “preselected” mice lack a pre-TCR (von Boehmer et al., 1998) as well
TCRlow DP thymocytes. as a TCR, thereby excluding the possibility that pMHCI
tetramer binding is a consequence of interaction with
the pre-TCR.CD8 Is Required for pMHCI Tetramers
to Bind DP Thymocytes
Given the bidentate nature of CD8 and TCR binding to Developmentally Altered CD8
Cell Surface GlycoformspMHCI (Connolly et al., 1990; Salter et al., 1990; Gao et
al., 1997; Kern et al., 1998), we needed to ascertain the Given that pMHCI tetramers bind to DP but not CD8 SP
thymocytes in the absence of detectable differences inindividual role of CD8 and the TCR in the peptide-indiffer-
ent pMHCI binding observed with Kb tetramers in non-tg CD8 and CD8 copy number by FACS or cell surface
distribution by confocal microscopy (data not shown),C57BL/6 mice. The contribution of CD8 to the pMHCI
Kb staining on DP thymocytes is demonstrated in Figure we next performed biochemical analysis of cell surface
CD8 heterodimers on unfractionated thymocytes, as2. Several independent lines of investigation suggest
that CD8 play a central role in this binding. For exam- well as individual thymocyte subpopulations, to identify
any qualitative changes in these glycoproteins. For thisple, as shown in Figure 2B, VSV8Kb staining could be
blocked by preincubating thymocytes for 1 hr with satu- purpose, freshly isolated thymocytes were surface labeled
using Sulfo-NHS-Biotin. Cells were then lysed in 1% Tritonrating concentrations of the anti-CD8mAb 53-5.8 prior
to VSV8Kb staining. The anti-CD8mAb CT-CD8blocks X-100 and subsequently immunoprecipitated with anti-
CD8 mAb and anti-CD8 mAb as well as the plantstaining as well but a second anti-CD8 mAb, 53-6.7,
does not (data not shown). These results imply that lectin PNA conjugated to CNBr-activated beads. Since
both CD8 and CD8 have multiple O-linked glycosyla-the CD8 heterodimer is critical for the demonstrated
Cell
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Figure 3. Resolution of Thymic CD8 and CD8 Glycoproteins and Their PNA Reactivity on SDS-PAGE Gels
(A) Proteins precipitated from lysates of cell-surface-biotinylated thymocytes of C57BL/6 or CD8/ thymocytes using Sepharose-coupled
anti-CD8 mAb-, anti-CD8 mAb-, or PNA-conjugated CNBr-activated Sepharose beads were resolved on 10% SDS-PAGE gels followed by
Western blotting with streptavidin-HRP.
(B) Equivalent analysis to (A), of isolated DP and CD8 SP thymocytes.
(C) 2D nonreducing/reducing 10% SDS-PAGE gel analysis of surface-labeled CD8 proteins immunoprecipitated with Sepharose-coupled anti-
CD8 mAb (53.6.7) from lysates of unseparated thymocytes, sorted DP and CD8 SP thymocytes and splenic T cells.
tion sites in their stalk region, alteration of such adducts SP thymocytes regardless of whether anti-CD8 or anti-
CD8 is used to immunoprecipitate the lysates. Follow-might be anticipated. Immunoprecipitates were re-
solved by SDS-PAGE, followed by Western blot analysis. ing differentiation of DP to SP thymocytes, reduced
CD8 heterogeneity is observed (compare Figure 3B,As shown in Figure 3A, CD8 and CD8 polypeptides
are clearly separable under reducing conditions and dif- lane 2 to 1 and lane 4 to 3). As revealed by PNA binding
analysis, most of the 27–30 kDa set of PNA bindingferentiated by comparing anti-CD8 and anti-CD8 im-
munoprecipitates of total thymocyte lysates from isoforms of CD8 is lost upon transition from DP to CD8
SP thymocytes whereas the 31–32 kDa CD8 isoformC57BL/6 versus CD8/ mice (Figure 3A). The CD8
subunit is resolved into a doublet with CD8 and CD8 is preserved (Figure 3B, lanes 5 and 6). Note by compari-
son the very weakly labeled CD8 components of thebands of approximately 38 and 33 kDa size ( is an
alternatively spliced CD8 gene product [Zamoyska et PNA binding CD8 heterodimers on DP thymocytes
whose lectin reactivity diminishes almost completelyal., 1985]). Greater heterogeneity is observed for the
CD8 subunit with multiple bands spanning the 27–32 upon further maturation. As sialic acid residue attach-
ment to Gal1-3GalNAc-Ser/Thr core 1 O-glycans maskskDa size range, as previously reported (Casabo et al.,
1994). Both CD8 and  are detected in anti-CD8 PNA binding reactivity (Pereira et al., 1976), O-linked
glycans on CD8 must undergo sialic acid modificationimmunoprecipitates of thymocyte lysates from C57BL/
6 and CD8/ animals (lanes 1–2) whereas no 27–32 during the DP to SP thymocyte transition, accounting
for the developmentally regulated reduction in PNA re-kDa CD8component is found in anti-CD8 immunopre-
cipitates from comparable lysates of CD8/ mice rela- activity with CD8 on CD8SP thymocytes. In sum, major
changes in the CD8 glycoprotein occur during thymo-tive to C57BL/6 mice (compare lane 2 and lane 1). Like-
wise, the anti-CD8 mAb immunoprecipitates both cyte maturation, involving the faster migrating 27–30
kDa isoforms.disulfide-linked CD8 and CD8 components from
C57BL/6 mice (lane 3), whereas no bands are detected The evolving nature of CD8 glycans during T cell
differentiation is further illustrated by two-dimensionalfrom anti-CD8 immunoprecipitates of anti-CD8/
thymocyte lysates (lane 4). non-reducing/reducing SDS-PAGE analysis of CD8 im-
munoprecipitates (Figure 3C). With the improved resolu-Evidence for developmentally regulated changes on
CD8glycans in the thymus of C57BL/6 mice is provided tion afforded by 2D gel analysis, reduction in CD8
biochemical heterogeneity upon maturation is readilyin Figure 3B. Clearly, differences exist between DP and
CD8 Core 1 O-Glycan Function
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observed. The CD8 glycoprotein heterodimers on total
thymocytes are complex, with at least three major sets
of  spots each representing a distinct pair of CD8
dimers (38Kd 30Kd, 38Kd29Kd, and 33Kd 28Kd).
Moreover, the nature of the CD8 spots suggests addi-
tional CD8 heterogeneity within these three dimers. In
comparison, DP thymocytes exhibit similar though not
identical complexity to unfractionated thymocytes, the
most noticeable difference being absence of smaller
CD8 glycoforms in the middle pair of CD8 dimers
(38Kd 29Kd). By the CD8 SP stage, a significant re-
duction in complexity has occurred, with a single 38 kDa
CD8 paired with a prominent 30 kDa CD8 glycoform.
Unstimulated splenic T cells exhibit a similar pattern to
CD8 SP thymocytes. Hence, total thymocytes reflect a
heterogeneous collection of glycosylated CD8 corecep-
tors relative to mature splenic T cells. This heterogeneity
largely represents the sum of CD8 heterodimers ex-
pressed on DP and CD8 SP thymocyte subsets. Al-
though not shown, deglycosylation with N-glycosidase
F does not reduce this heterogeneity, arguing that the
CD8 modifications occurring during the DP to CD8 SP
transition are not associated with prominent changes in
N-linked glycans.
CD8 Glycans Are the Key Developmental
Modulators of pMHCI Binding
on Thymocytes
Glycans add mass and definable structure as posttrans-
Figure 4. Increased PNA and SIYRKb Tetramer Binding on CD8 SPlational modifications, and some saccharides, such as
Thymocytes Pretreated with Neuraminidasesialic acid, impart a negative charge. It is possible that
Thymocytes from C57BL/6 mice were pretreated with 20 mU ofthe binding events involving MHCI and CD8 coreceptors
neuraminidase (Vibrio cholerae) at 37	C for 30 min.might be significantly affected by variation in the CD8
(A) PNA reactivity revealed by staining with FITC-labeled PNA plus
glycan adducts on DP and CD8 SP thymocytes. To directly anti-CD4 plus anti-CD8 specific mAbs. PNA reactivity gated in
ascertain whether glycosylation modulates pMHCI tetra- CD8SP (SP, top panel) and DP (DP, bottom panel) in untreated
mer binding, thymocytes were treated with neuramini- (open) and neuraminidase-treated (shaded) subsets is shown. The
PNA MCF is 418 for nontreated and 1649 for neuraminidase treateddase to remove sialic acid residues from O-linked gly-
CD8 SP thymocytes. A small subset of untreated SP cells (
16%)cans and, in so doing, unmask the PNA binding site
of unknown function are PNAhigh (data not shown).(Pereira et al., 1976). As shown in Figure 4A (upper
(B) Induction of SIYRKb tetramer binding on neuraminidase-treated
panel), neuraminidase treatment of CD8 SP C57BL/6 CD8SP thymocytes. Changes in tetramer binding to CD8 SP thymo-
thymocytes results in an increased PNA binding by more cytes after neuraminidase treatment are shown relative to untreated
than one order of magnitude. In contrast, there is only DP thymocytes. The MCF for CD8SP thymocytes increases from
5.1 for nonneuraminidase treated cells (2296 events analyzed) toa slight increase in PNA binding observable within the
71.2 (2947 events analyzed) after treatment. Untreated DP thymo-DP thymocyte subset of the same animal, as expected
cytes have an MCF of 182.9. Percentages of cells binding tetramer(Figure 4A, lower panel). This result is consistent with the
are 83%, 3.5%, and 53% for DP, CD8 SP, and treated CD8 SP,
greater number of sialic acid adducts on core 1 O-glycans respectively.
on SP versus DP thymocytes. More importantly, Figure
4B shows that there is a greater than 10-fold increase
in SIYRKb tetramer staining in neuraminidase-treated
CD8 SP thymocytes relative to untreated CD8 SP thymo- enzymatic desialylation, we sought to define further the
cytes. In fact, following neuraminidase treatment, the glycan type involved and determine how this process
level of pMHCI tetramer binding approximates that of is controlled endogenously by sialyltransferase gene
untreated DP thymocytes. Increased SIYRKb tetramer function. To this end, we analyzed thymocytes deficient
staining of CD8 SP thymocytes pretreated with neur- in the sialyltransferase ST3Gal-I (Priatel et al., 2000) and
aminidase in conjunction with enhanced PNA reactivity C57BL/6 mice of the same age (6.5 weeks). ST3Gal-I
emphasizes the involvement of glycans in mediating modulates O-glycan biosynthesis by sialylating O gly-
thymocyte-MHCI interactions. cans, exhibiting specificity for the PNA-reactive core 1
O-glycan Gal1-3GalNAc–Ser/Thr expressed on the cell
surface of cortical thymocytes (Gillespie et al., 1993;The ST3Gal-I/ Sialyltransferase Is Responsible
for Modifying pMHCI Tetramer Binding Kono et al., 1997). In the absence of the ST3Gal-I en-
zyme, sialylation of core 1 O-linked glycans is reducedto CD8 SP Thymocytes
Having demonstrated that pMHCI tetramer binding to (Priatel et al., 2000). As shown in Figure 5A, the ST3Gal-
I deficiency is associated with increased VSV8Kb stain-cell surface CD8 heterodimers is influenced by in vitro
Cell
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Figure 5. VSV8Kb Staining of CD8SP Thymo-
cytes Is Increased in ST3Gal-I/ Mice
(A) Thymocytes from 6-week-old ST3Gal-I/
and C57BL/6 mice were triple stained with
anti-CD8 and anti-CD4 mAbs plus PE-
labeled VSV8Kb tetramer. Tetramer staining
of the CD8SP thymocytes is shown in the
bottom two panels. Percentages of tetramer
reactive CD8SP thymocytes are 6.0/6.2 and
22.6/26.3 for B6 and ST3Gal-I/ mice, re-
spectively. Although not shown, the tetramer
staining pattern of DP thymocytes is similar
for both strains of mice. Results are represen-
tative of 4 animals of each type studied.
(B) PNA reactivity of CD8 SP (left panel) and
DP thymocytes (right panel) from ST3Gal-I
heterozygous (/) and homozygous (/)
mutants.
(C) Reduction in mature CD8 SP thymocytes
in ST3Gal-I/. Indicated marker analysis by
three-color method, with numbers indicating
the percentage of positive cells.
ing of CD8 SP thymocytes compared to control C57BL/6 in ST3Gal-I homozygotes while significantly reduced in
heterozygotes relative to DP thymocytes. Furthermore,mice. Analysis of ST3Gal-I knockouts and littermate
controls resulting from mating of ST3Gal-I/ and Figure 5A shows that a specific subset of CD8 SP thymo-
cytes is markedly reduced (bracket) in this sample whichST3Gal-I/ parents yielded comparable results (data
not shown). Two representative C57BL/6 and ST3Gal- is representative of 5 ST3Gal-I/ mice tested (data not
shown). Reduced percentages of CD5 and Qa-2 cellI/ mice were analyzed in parallel. The percents of CD8
SP thymocytes reactive with VSV8Kb were 6.01 and 6.2 for staining and increased HSA staining confirms that there
are fewer mature positively selected CD8 SP thymocytesthe C57BL/6 mice, and 22.63 and 26.29 for the ST3Gal-I/
mice. The higher percentage of tetramer-reactive ST3Gal-I in ST3Gal-I/ mice (Figure 5C). The diminished CD69
expression in these animals is also consistent with re-CD8 SP thymocytes is also reflected in higher MCF values
quantified from all CD8 SP cells analyzed in each mouse. duced positive selection (Amsen et al., 1999), i.e., nega-
tive selection is more pronounced.For example, MCF values for the PE-avidin control were
2.97 and 2.06 versus 10.72 and 11.06 for the VSV8Kb tetra- Given that CD8 O-glycans on thymocytes are impor-
tant modifiers of CD8-MHCI interaction as shown above,mer, respectively, in the two C57BL/6 mice analyzed.
The corresponding values for the two ST3Gal-I/ mice alterations in CD8 O-glycosylation might modulate TCR
selection. To examine this possibility, we analyzed TCRwere similar for PE-avidin (2.92 and 2.87) but higher for
VSV8Kb (31.79 and 42.41). V repertoires in ST3Gal-I/ mice and their littermate
ST3Gal-I/ controls. The results are presented in TableThe increased VSV8Kb staining of CD8 SP thymocytes
from ST3Gal-I/ correlates with the PNAhigh phenotype 1 and demonstrate statistically significant differences
in TCRBV 5.1/2, 9, 11, and 14. As these two sets ofresulting in the mutant mice. As shown in Figure 5B,
although DP thymocytes from ST3Gal-I homozygotes animals were backcrossed to C57BL/6 at least five
times, we interpret the differences as resulting from vari-and heterozygotes have similar PNAhigh phenotypes, the
PNA-FITC staining of CD8 SP thymocytes remains high ation in glycosylation in ST3Gal-I/ versus ST3Gal-I/
CD8 Core 1 O-Glycan Function
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Table 1. TCR V Repertoire Analysis in ST3Gal-I/ Mice and ST3Gal-I/ Littermate Controls
ST3Gal-I/ ST3Gal-I/ littermate controls
TCRV M1 M2 M3 M4 mean  SD M1 M2 M3 M4 mean  SD
2 4.79 4.13 3.35 4.63 4.23  0.65 3.79 4.04 3.82 4.33 4.00  0.25
3 1.83 2.05 2.13 2.39 2.10  0.23 1.56 2.43 1.88 1.46 1.83  0.44
4 4.15 3.58 3.29 3.03 3.51  0.48 3.17 2.97 3.17 2.25 2.89  0.44
5.1/2* 13.86 12.63 17.90 13.08 14.37  2.41 7.39 10.34 9.47 9.29 9.12  1.24
6 5.59 5.39 5.27 7.01 5.82  0.81 5.83 5.36 5.33 4.62 5.29  0.50
7 4.89 4.80 5.16 5.12 4.99  0.18 6.04 3.72 4.65 4.15 4.64  1.01
8.1/2 10.11 12.84 12.82 13.83 12.40  1.60 9.77 12.21 8.99 9.03 10.00  1.52
8.3 6.39 5.41 4.87 5.52 5.55  0.63 7.65 5.30 2.70 3.88 4.88  2.13
9* 2.49 3.13 2.66 2.88 2.79  0.28 1.61 1.84 1.68 2.30 1.86  0.31
10 3.43 4.66 4.08 3.92 4.02  0.51 2.38 4.09 2.93 2.77 3.04  0.74
11* 4.70 4.46 5.72 4.64 4.88  0.57 4.31 3.53 3.96 3.11 3.73  0.52
12 2.22 1.97 1.76 2.72 2.17  0.41 1.12 1.53 2.17 1.20 1.51  0.48
13 3.26 3.44 3.74 2.75 3.30  0.42 1.70 2.75 2.82 2.07 2.34  0.54
14* 2.13 2.48 2.07 2.13 2.20  0.19 1.85 1.72 1.64 1.67 1.72  0.09
Four-week-old ST3Gal-I knockout mice and ST3Gal-I heterozygous littermate controls were used for these studies. Statistical analysis was
done using the two-sided Wilcoxen ranked t test. Triple color analysis with anti-CD4, anti-CD8, and anti-V mAbs were employed and
percentage of CD8 SP thymocytes examined as described in Experimental Procedures.
* Shows significant differences (p  0.05%).
mice. In conjunction with the above results, these find- 1993). The CD8 chain is key in pMHC binding, irrespec-
tive of the peptide sitting in the MHCI groove as assayedings offer a compelling argument for the important role of
ST3Gal-I and O-linked glycosylation in CD8-dependent by Kb tetramer staining. Thus, pMHCI tetramer binding to
normal C57BL/6 DP thymocytes is blocked by saturatingpMHCI thymic selection.
concentrations of anti-CD8 mAb (53-5.8), and detect-
able pMHCI tetramer binding is essentially absent inDiscussion
CD8/ mutant mice. These results are consistent with
two recent studies showing that pMHCI Kb bindingThe fate of a developing thymocyte is determined by
the bidentate interaction of its TCR and coreceptor (CD4 to peripheral T cells was inhibited by anti-CD8 mAb
53-5.8 (Daniels and Jameson, 2000) and that MHCI DKor CD8) with pMHC complexes expressed on thymic
stromal cells. Those immature thymocytes that bind with tetramers bound with greater avidity to thymocytes ex-
pressing CD8 receptors rather than CD8 receptorsgreatest avidity to self-pMHC complexes are actively
eliminated by an apoptotic negative selection mecha- (Bosselut et al., 2000). Furthermore, evidence from nu-
merous studies supports a unique role for CD8 in bothnism, while those binding with weak self-reactivity are
chosen for survival (positive selection) (Goldrath and Be- the selection and function of CD8 lineage T cells
(Wheeler et al., 1992; Crooks and Littman, 1994; Naka-van, 1999; Sebzda et al., 1999). In this study, we have
demonstrated that a significant proportion of immature yama et al., 1994; Luescher et al., 1995).
DP thymocytes binds pMHCI Kb complexes through a
CD8 heterodimer-dependent mechanism. More im- Developmentally Regulated Modification
of the Glycans Attached to CD8portantly, the strength of binding is developmentally
regulated by a posttranslational modification involving As posttranslational modifications of proteins bound for
the cell surface or secreted into the extracellular milieu,sialic acid. At the DP thymocyte stage, the core 1 O-linked
glycans are devoid of sialic acid and thus are strongly glycan structures are highly diverse and influence glyco-
protein synthesis, stability, and function (reviewed inPNA reactive, binding pMHCI complexes more avidly
than SP thymocytes whose sialylated O-glycans mani- Varki, 1993). Studies of specific glycans by genetic and
structural approaches have recently revealed severalfest PNAlow reactivity. Of note, expression of ST3Gal-I
sialyltransferase responsible for core 1 sialic addition is examples of important roles in modulating the verte-
brate immune system (reviewed in Lowe, 2001; Rudd etupregulated at the CD8 SP thymocyte stage (Gillespie
et al., 1993; Baum et al., 1996). Consistent with the im- al., 2001). During T cell ontogeny, the glycan adducts
of thymocyte surface glycoproteins undergo specificportant role of sialic acid modification of CD8O-linked
stalk region glycans in functional pMHC binding is the modifications that can be probed using lectins for cell
surface glycosylation typing. The altered reactivity ofability of sialidase treatment of normal CD8 SP thymo-
cytes to enhance pMHCI binding. Likewise, an ST3Gal-I developing thymocytes to the plant lectin PNA is a well
known example in immunological studies (Reisner etknockout mutation upregulates pMHCI interaction with
CD8 SP thymocytes. The enhanced CD8-pMHCI inter- al., 1976); DP thymocytes display a PNAhigh phenotype,
whereas CD8 SP thymocytes are PNAlow due to the de-action at the DP thymocyte stage likely alters T cell reper-
toire generation in a significant way, as specified below. velopmental and genetic induction of ST3Gal-I sialyl-
transferase activity, which converts Gal1-3GalNAc-On thymocytes, the vast majority of CD8 coreceptor
molecules are of the CD8 isotype, underscoring the Ser/Thr into Sia2-3Gal1-3GalNAc-Ser/Thr (Gillespie
et al., 1993; Baum et al., 1996; Kono et al., 1997) (seeimportance of the CD8 subunit in T cell development
and function (Walker et al., 1984; Miceli and Parnes, Figure 4A). The distribution of PNA–specific glycans on
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the surface of developing thymocytes appears to be involved prominently. Furthermore, it follows that since
CD8 is the major determinant of DP thymocyte-MHCIrestricted to fewer than a dozen molecules including
CD8, CD43, and CD45 (Wu et al., 1996; Priatel et al., binding, glycosylation of the CD8 stalk region may
modulate CD8-pMHCI interaction and affect selection.2000). Thymocytes bearing glycoproteins with exposed
core 1-O glycan Gal1-3GalNAc have a PNAhigh pheno- Current evidence in support of a unique role for CD8
in T cell selection derives from studies of thymocytestype, whereas those with sialylated core-1 glycans are
PNAlow (Pereira et al., 1976). Binding of PNA to devel- in CD8null mice expressing a tg TCR where impairment
of both positive and negative selection is observedoping thymocytes is thus inversely correlated with sialic
acid addition to O-linked core-1 glycans. (Crooks and Littman, 1994).
These findings suggest that alterations in the strengthConsistent with these findings, SP thymocytes from
mice lacking the ST3Gal-I sialyltransferase show an in- of the CD8-pMHCI interaction via O-linked glycosyla-
tion modifications in the coreceptor stalk region willcrease in PNA binding and a 3- to 4-fold increase in CD8
SP-Kb tetramer staining compared to littermate controls. affect selection processes. In the preselected DP thy-
mocyte compartment where core 1 O-linked glycans areAlthough the increase in pMHCI binding to CD8 SP thy-
mocytes in ST3Gal-I/ animals is not as great as that least sialylated, pMHCI interaction is the greatest, as
shown by Kb tetramer binding studies. At this stage,resulting from enzymatic sialidase treatment of cell sur-
faces, a significant proportion of cells attain similar autoreactive TCR specificities would be most efficiently
eliminated by negative selection through enhanced cor-pMHCI binding levels. Several explanations are plausi-
ble that reflect physiologic mechanisms, unlike that ob- eceptor function. The same CD8 glycoforms will also
aid in positive selection within the DP thymocyte com-tained by global enzymatic de-sialylation in vitro. The
decrease in core 1 O-glycan sialylation affected by the partment since the requisite threshold required to in-
duce survival/differentiation signals can be achievedST3Gal-I null mutation disables a synthetic block in core
2 O-glycan synthesis, and may result in a sialic acid with assistance of the CD8 affinity boost. In this way,
very low affinity self-pMHC ligands may still serve as amoiety residing on the core 2 O-glycan branch (Priatel
et al., 2000). This sialic acid may also modulate pMHCI positively selecting stimulus for a given TCR. Once a
thymocyte has differentiated to the CD8 SP stage andbinding. Sialidase treatment would remove these termi-
nal sialic acid residues in addition to those attached to is exported to the peripheral T cell compartment, CD8
O-glycan sialylation will reduce the strength of thecore 1 O-glycan structures.
ST3Gal-I is one of at least eighteen sialyltransferase CD8 coreceptor interaction with pMHCI, mandating
a greater requirement for TCR-pMHCI interaction toenzymes known to exist in the vertebrate genome, some
of which generate a sialic acid linkage on the N-acetylga- achieve a subsequent activation threshold. Such a fail-
safe mechanism could provide further protectionlactosamine proximal to the serine and threonine resi-
dues of the O-glycosylated glycoprotein. Typically, sia- against peripheral T cell autoreactivity. Analysis of the
total CD8 SP thymocyte subset in ST3Gal-I/ mice (Fig-lyltransferases exhibit unique substrate specificity for
various glycans as well as restricted patterns of expres- ure 5C) argues that the overall repertoire in these non-
tg mice is shifted toward more pronounced negativesion in cell types and during differentiation (Paulson et
al., 1989; Kitagawa and Paulson, 1994; Priatel et al., selection.
2000). When considered with the stepwise regulation
of O-glycan synthesis and diversification in the Golgi The CD8 Stalk: Influence of Glycosylation
(reviewed in Marth, 1999), one or more of the ST6GalNAc on Binding Function
sialyltransferases may operate on the sialylated core 1 How do changes in the O-linked glycan adducts of the
O-glycan in SP thymocytes. The resulting structure, thymic CD8 coreceptor influence its binding activity?
termed “disialyl T antigen” has been found among T A comparison of CD8 and CD8 protein sequences in
cells (Piller et al., 1988), and could contribute a second the stalk segment which bridges the V-like Ig domain
sialic acid reflected in the tetramer binding difference and transmembrane helix is shown for four mammalian
observed between neuraminidase and ST3Gal-I defi- homologs in Figure 6A. Certain conserved features of
ciency. We also cannot preclude the involvement of the stalks are readily apparent. First, the CD8 stalks are
sialylated glycolipids that can modify receptor glycopro- 12–15 aa shorter than the corresponding CD8 stalks,
tein function (Rebbaa et al., 1996). consistent with the view that CD8 likely occupies the
“top” position of the CD8 dimer during interaction with
pMHCI (Figure 6B) and is hence closest to the T cellT Cell Selection
In ST3Gal-I/ mice, loss of enzymatic activity minimally membrane (Kern et al., 1998). Note that the register of
the two stalk regions is well defined by the position ofinfluences total thymocyte viability (Priatel et al., 2000).
However, comparison of the TCR V repertoire in CD8 two sets of membrane-proximal cysteine residues that
form interchain disulfide bonds. Second, the conservedSP from ST3Gal-I/ homozygote and heterozygote lit-
termates indicates an influence on T cell selection with predicted O-linked glycosylation sites (Hansen et al.,
1997) within the stalks (3 for CD8 and 2 for CD8)significant differences occurring in TCR V5.1/2, 9, 11,
and 14. Because ST3Gal-I can sialylate core 1 O-glycans are in close proximity to the V-like head regions of each
subunit. Third, the CD8 stalk contains five conservedattached to both CD8 and CD8 stalks as well as CD43
and CD45, we cannot identify the O-glycan(s) that con- lysine residues not present in the corresponding CD8
sequences. These lysyl side chains may permit interac-tributes greatest to the observed effect on T cell selec-
tion. The large differences in CD8 O-glycans on DP tion with noncharged carbohydrate moieties of the
O-linked glycan via their aliphatic side chains and yetversus SP thymocytes (Figure 3) argue that CD8 is
CD8 Core 1 O-Glycan Function
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Figure 6. A Model to Account for O-Linked Glycosylation-Mediated Changes in the CD8 Interaction with pMHCI
(A) Sequence comparison of CD8 (top) and CD8 (bottom) stalk regions of four species. The predicted highly conserved O-linked glycosylation
sites (Hansen et al., 1997) are designated by diamond/stick figures. Positively charged residues are indicated by (). Conserved cysteines in
the membrane proximal stalk postulated to form interchain disulfide bonds are indicated. Note the insertion of the two segments in CD8
relative to CD8 marked by solid bars with dashes representing corresponding gaps in CD8.
(B) Representative model of the CD8 interaction with VSV8Kb based upon the VSV8Kb-CD8 complex where CD8 is viewed as replacing
CD81 in the crystal structure model (Kern et al., 1998). The CD8-VSV8Kb complex is a RASTER 3D rendered MOLSCRIPT drawing (Kraulis,
1991; Merritt and Murphy, 1994). In the figure, Kb is in blue, the postulated CD8 position is in red and the CD8 subunit in green. Note how
CD8 clamps the protruding Kb 3 CD loop.
(C) Transmembrane CD8 heterodimers on DP and CD8 SP thymocytes. In DP thymocytes, the O-glycan structures comprise unsialylated
core 1 O-glycans and branched core 2 O-glycans that are postulated to hold the Ig domains in a rigid configuration promoting the interaction
between the globular CD8 (red) and CD8 (green) heads and MHC 3 domain (with only the CD loop of Kb in blue shown for simplicity).
Sialylation of core 1 O-glycans by ST3Gal-I during the DP to SP transition inhibits core 2 O-glycan biosynthesis on CD8 SP thymocytes. The
negatively charged sialic acid added to each core 1 glycan causes repulsion of the adjacent stalk segments, producing an altered orientation
and/or stability of the CD8 head region, such that pMHCI binding is reduced.
assist with hydration through the formal charge on each O-glycans, particularly in the CD8 stalk, could confer
structural rigidity to the segment, thereby assisting inresidue. As noted, other points of conservation among
homologs of CD8 or CD8 are present, but distinct association of the weakly interacting CD8 Ig domains,
stabilizing each head to facilitate optimal binding to thedifferences in CD8 versus CD8 subunit sequences
are also evident. MHCI 3 domain. The important domain-domain associ-
ation function of the proximal stalk region is compellingThe combined presence of glycans and prolines indi-
cates that the stalk most likely adopts extended conforma- in view of the conservation of O-linked sites abutting
the Ig domains (Figure 6A) and the weak association oftions, similar to that observed for leukosialin and mucins.
When mucins are heavily O glycosylated, they exhibit a CD8 and CD8 Ig domains in solution (our unpublished
observations). By contrast, the addition of negatively3-fold expansion in chain dimension compared to their
unglycosylated counterpart (Classon et al., 1992; Rudd charged sialic acids to the CD8 O-glycans during thymic
maturation will force the stalks apart, accommodatinget al., 1999 and references therein). Our prediction for how
O-glycans might be affecting CD8 coreceptor conforma- the additional bulk of the adducts and unfavorable
charge clustering. The juxtaposition of the O-glycanstion and therefore MHCI interactions are presented in car-
toon form in Figure 6C. The presence of unsialylated proximal to the CD8 Ig domains is likely to significantly
Cell
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Tetramer Productionimpact CD8 domain-domain association. In the com-
Tetramers consisiting of complexes of H-2Kb refolded with the VSV8plete or near absence of sialic acid addition to core 1
(RGYVYQGL), dEV8 (EQYKFYSV), or SIYR (SIYRYYGL) peptidesO-glycan adducts on DP thymocytes, the CD8 and
were produced using the method previously described (Moody et
CD8 Ig domains will approximate one another, reach- al., 2001).
ing to and clamping the MHCI 3 CD loop (Kern et al.,
1998) in the most optimal manner. By contrast, sialic Cell Surface Staining and Flow Cytometric Analysis
For immunofluorescence analysis, 106 thymocytes or splenicacid addition to core 1 O-glycans of CD8 coreceptors
T cells were resuspended in 0.1 ml PBS containing 2% FCS plusmay force a conformational alteration of the stalk region
5 mM sodium azide. The splenic T cell-enriched population wasabutting the head piece, modifying CD8-CD8 Ig do-
obtained by depletion of B cells and macrophages using the MACS
main-domain association and/or orientation to weaken separation system with BioMag goat anti-mouse IgG particles (Per-
pMHCI interaction function on SP thymocytes (Figure spective Biosystems, Framingham, MA) and an anti-class II I-Ab
specific mAb (AF6-120.1). Thymocytes and splenocytes were incu-6C). With respect to overall CD8 orientation, neutral-
bated with 0.5 g FITC-labeled anti-CD8 (53-6.7, PharMingen) andization of the positive charge of each lysine by sialic
50 ng FITC-labeled anti-CD8 mAbs (53-5.8, PharMingen) at 4	C foracid may lead to reduction in the length of the CD8
1 hr. Cy-chrome-labeled anti-CD4 (H129.19, PharMingen) plus 1.4stalk, no longer necessitating its full extension and
g PE-labeled VSV8Kb, dEV8Kb, or SIYRKb tetramers were added
hence diminishing accessibility to pMHCI. Thus, while and the cells incubated for another hour. After 3 washes (PBS plus
the six CDR-like loops of the CD8 dimer are responsible 2% FCS), cells were analyzed on a FACScan (Becton Dickinson)
using Cellquest software within 2 hr of staining. Neuraminidasefor pMHCI binding (Figure 6B) (Gao et al., 1997; Kern et
treatment of thymocytes was performed using 20 mU of sialidaseal., 1998), the stalk regions appear to modulate CD8-
from Vibrio cholerae (Roche Diagnostics) as described previouslypMHCI interaction through distal conformational/orien-
(Wu et al., 1996) prior to tetramer staining.tational change (Figure 6C).
CD8 O-glycosylation comprises a highly regulated Repertoire Analysis
change in sialic acid that we have found modifies corecep- Thymocytes were isolated from ST3Gal-I/ homozygotes and con-
trol ST3Gal-I/ heterozygous littermates. One hundred microlitertor function on thymocytes, effecting pMHC ligand binding
aliquots of 1  106 thymocytes/ml were incubated with PE-labeledand thymic selection. Our findings identify this conserved
anti-CD4, cy-chrome-labeled anti-CD8, plus an FITC-labeled TCRevent in thymic T cell differentiation as involving altered
V-specific mAb from a mAb panel (PharMingen). After 30 min, cells
expression of the gene encoding the ST3Gal-I sialyltrans- were washed 1 time in FACS buffer and analyzed by FacScan,
ferase. What parameters might altered O-glycan sialyla- through a CD8 SP thymocyte gate.
tion modulate in mature effector T cells? Currently, it is
Biotin Labeling of Cell Surface Molecules,known that activation of peripheral T cells is associated
Immunoprecipitation, SDS-PAGE, and Western Blot Analysiswith desialylation of core 1 O-glycans and induction of
Biotinylation was performed according to established methods withcore 2 O-glycans (Piller et al., 1988; Priatel et al., 2000).
thymocytes washed 2 times in PBS buffer containing 1 mM MgCl2
Desialylation of core 1 O-glycans occurs sometime after plus 0.1 mM CaCl2, resuspended in PBS buffer containing EZ-link
the peak of the T cell response and has recently been sulfo-NHS-Biotin (PIERCE, Rockford, IL) at a concentration of 50
ng biotin per 107 cells and rotated at 4	C for 30 min. Labeling wasproposed to comprise an apoptotic mechanism for
terminated by 2 washes in lysine-rich RPMI media. Biotin-labeledclearing post-activated CD8 T cells that have not re-
CD4-sorted thymocytes were lysed in buffer containing 1% Tritonceived differentiative signals to become memory cells
X-100, 50 mM Tris (pH 7.5), and 150 mM NaCl at 4	C for 1 hr. Post-
during the resolution of an immune response (Priatel et nuclear supernatants were precleared with 2H11 (leucine-zipper-
al., 2000). O-glycosylation changes on the CD8 molecule specific mAb)-conjugated cyanogen bromide (CNBr) activated
itself have not been directly linked to peripheral apopto- beads, followed by immunoprecipitation with anti-CD8-conjugated
(53.6.7), anti-CD8 (YTS)-conjugated, or peanut agglutinin (PNA)-sis of CD8 CTL in the ST3Gal-I/ model. However, al-
conjugated CNBr activated beads, for 2–3 hr at 4	C. Precipitatestered CD8 glycosylation resulting from the action of
were washed 4 times in TBS buffer (50 mM Tris [pH 7.5] and 150other siayltransferases or sialidases may play a role in mM NaCl) and eluted from the beads in 2% SDS sample buffer.
T cell effector function. In this regard, it is clear that For 2D analysis, immunoprecipitates were run on 10% nonreducing
alterations of glycans are tightly regulated on CD8 and SDS-PAGE gels in the first dimension. Individual lanes were excised
from the gel, soaked in reducing sample buffer (containing 7.5%other T cell surface molecules. Detailed site-specific
glycerol, 60 mM Tris [pH 6.8], 2%SDS, and 0.6 M -2 mercaptoetha-structural analysis of these glycans is now required to
nol) for 30 min and placed onto a 10% SDS-PAGE gel for electropho-dissect their important modulatory roles in both thymic
resis in the second dimension.
and peripheral T cell compartments. The precipitated proteins separated under reducing conditions
on a 10% SDS-PAGE gel were transferred to Immobilon P membrane
(Millipore, Bedford, MA) in buffer containing 25 mM Tris, 0.2 M glycine,
Experimental Procedures and 20% methanol at 100V for 1 hr. Blots were washed 3 times in
TBST buffer (TBS plus 0.05% Tween 20) for 10 min and blocked
Animals with a solution of 5% BSA in TBST at 4	C overnight with shaking.
RAG-2/ mice carrying the N15 TCR transgenes (Ghendler et al., Blots were washed 3 times in TBS-T and incubated with HRP-conju-
1997) were backcrossed to C57BL/6 (H-2b) mice for ten generations gated streptavidin diluted 1 in 20,000 in TBST (ICN Biochemicals,
prior to intercrossing. Homozygous N15tg RAG-2/ H-2b animals OH) for 1 hr. Unbound HRP-streptavidin was removed by 3 TBST
were obtained and used. C57BL/6, RAG-2/, and RAG 2/ mice washes. Biotin-labeled proteins were visualized by chemilumines-
were purchased from Taconic (Germantown, NY). Balb/cJ, AKR/J, cence, performed according to manufacturer’s instructions (NEN
and CD8/ mice were purchased from the Jackson Laboratory Life Science Products, Boston, MA) and autoradiography.
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Note Added in Proof
Since this work was submitted, we learned of a related effort which
independently demonstrates that CD8 binding to MHC class I mole-
cules is developmentally regulated through glycosylation. (Daniels,
M.A., Devine, L., Miller, J.D., Moser, J.M., Lukacher, A.E., Altman,
J.D., Kavathas, P., and Jameson, S.C. (2001). CD8 binding to MHC
class I molecules is influenced by T cell maturation and glycosyla-
tion. Immunity, in press).
